PepGen to Participate in Upcoming Investor Conferences

Businesswire11/04 21:00

Avidity Gets FDA Partial Clinical Hold Lifted on DM1 Drug Candidate

Seeking Alpha10/04 01:13

PepGen Announces Christopher Ashton, PhD, to Retire From Its Board of Directors

Businesswire09/20 04:30

Is PepGen Inc. (NASDAQ:PEPG) Trading At A 34% Discount?

Yahoo Finance08/17 20:37

PepGen GAAP EPS of -$0.87

Seeking Alpha08/09 19:58

Wedbush Adjusts PepGen's PT to $19 From $20, Keeps Outperform Rating

MT Newswires08/08 23:22